ATM and glioblastoma: We demonstrated that the mechanism of axitinib-triggered senescence in glioblastoma cellular models in vitro (bulk tumor cells and patient-derived glioblastoma stem cells—GSCs) is dependent on the intracellular accumulation of reactive oxygen species (ROS) and the activation of the ATM (ataxia telangectasia mutated) kinase.